Vaxart says stop-work order was lifted on next-gen Covid vaccine news2025-04-28T18:43:51+00:00April 28th, 2025|Endpoints News|
Novavax responds to FDA’s request for new Covid vaccine trialnews2025-04-28T17:48:21+00:00April 28th, 2025|Endpoints News|
WuXi AppTec sees revenue growth after 2024’s declinenews2025-04-28T17:20:03+00:00April 28th, 2025|Endpoints News|
Daiichi Sankyo says production boost in US will help cushion tariff impactnews2025-04-28T14:44:32+00:00April 28th, 2025|Endpoints News|
Merck KGaA to buy rare cancer biotech SpringWorks for $3.9Bnews2025-04-28T12:19:13+00:00April 28th, 2025|Endpoints News|
European regulators recommend new drugs from Vertex, Amgen and Jazz news2025-04-28T11:03:11+00:00April 28th, 2025|Endpoints News|
France stops Valneva’s chikungunya vaccine rollout in over 65s after safety issuenews2025-04-28T11:00:35+00:00April 28th, 2025|Endpoints News|
#AACR25: GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancernews2025-04-28T10:36:06+00:00April 28th, 2025|Endpoints News|
FDA chief Makary talks expediting drug approvals, RIFs and the abortion pillnews2025-04-25T19:27:20+00:00April 25th, 2025|Endpoints News|
AbbVie eyes $10B US expansion amid sector-specific tariff threatnews2025-04-25T19:19:56+00:00April 25th, 2025|Endpoints News|
